Triple Antibiotic Paste vs Simvastatin for Lesion Sterilization and Tissue Repair in Primary Molars.

NCT ID: NCT07264842

Last Updated: 2025-12-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

PHASE2

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-06-26

Study Completion Date

2026-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This randomized, double-blinded, parallel-controlled clinical trial aims to compare the effectiveness of Triple Antibiotic Paste (TAP) and Simvastatin in Lesion Sterilization and Tissue Repair (LSTR) of primary molars with pulp necrosis.

A total of 60 children (aged 5-8 years) with non-vital primary molars will be recruited from the Department of Operative Dentistry and Endodontics, Dow International Dental College, Karachi. Participants will be randomly assigned to one of two groups:

Group 1 (Control): LSTR using Triple Antibiotic Paste (Ciprofloxacin + Metronidazole + Cefixime).

Group 2 (Intervention): LSTR using Simvastatin paste.

Both materials will be placed after non-instrumentation cleaning and sealed with glass ionomer cement, followed by stainless steel crown placement. Patients will be evaluated clinically and radiographically at 1, 2, and 3 months post-treatment.

Primary outcomes include clinical success (absence of pain, swelling, or sinus tract) and radiographic success (reduction or absence of periapical radiolucency). Data will be analyzed using SPSS v26, with chi-square and t-tests applied as appropriate; p \< 0.05 will be considered significant.

This study seeks to determine whether Simvastatin, owing to its antibacterial, anti-inflammatory, and regenerative properties, can serve as a viable alternative to antibiotic-based LSTR in managing necrotic primary teeth.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pulpal Necrosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Simvastatin

Lesion Sterilization and Tissue Repair using Simvastatin.

Group Type EXPERIMENTAL

Lesion Sterilization and Tissue Repair

Intervention Type COMBINATION_PRODUCT

Lesion sterilization and Tissue Repair includes removal of any debris from the pulp chamber of the primary tooth and filling with triple antibiotic paste or simvastatin followed by sealed with the restoration.

Triple Antibiotic Paste

Lesion Sterilization and Tissue Repair using triple antibiotic paste

Group Type ACTIVE_COMPARATOR

Lesion Sterilization and Tissue Repair

Intervention Type COMBINATION_PRODUCT

Lesion sterilization and Tissue Repair includes removal of any debris from the pulp chamber of the primary tooth and filling with triple antibiotic paste or simvastatin followed by sealed with the restoration.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Lesion Sterilization and Tissue Repair

Lesion sterilization and Tissue Repair includes removal of any debris from the pulp chamber of the primary tooth and filling with triple antibiotic paste or simvastatin followed by sealed with the restoration.

Intervention Type COMBINATION_PRODUCT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Young, healthy patient, ranging in age from 5-8 years.
* Has parents/ guardians who give consent to allow their minor to participate in the study and willing to monitor their progress.
* Having maxillary and mandibular primary molars with:

* Spontaneous pain or tenderness to percussion.
* Deep cavity extending to the pulp chamber.
* Chronic Abscess or draining sinus.
* Restorable.
* To be kept for less than a year.
* Irregular mobility that is not related to exfoliation.

Exclusion Criteria

* Uncooperative patients.
* Children with a history of allergic reaction with antibiotics.
* Teeth with physiological root resorption but root length is more than two thirds, root canal obliteration, severe internal resorption, internal calcifications, or piercing into the bifurcation.
Minimum Eligible Age

5 Years

Maximum Eligible Age

8 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Dow University of Health Sciences

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Waleed Mumtaz

Postgraduate Trainee- FCPS

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Prof.Dr. Farah Naz Biyabani, FCPS

Role: STUDY_DIRECTOR

Dow University of Health Sciences

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Dow International Dental College, Chanesar goth.

Karachi, Sindh, Pakistan

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Pakistan

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Muhammad Waleed Postgraduate Trainee, FCPS

Role: CONTACT

923222046451

Prof. Dr. Farah Naz Supervisor, FCPS

Role: CONTACT

03002345434

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Muhammad Waleed Postgraduate Trainee - FCPS, BDS

Role: primary

923222046451

Prof.Dr. Farah Naz Supervisor, FCPS

Role: backup

03002345434

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

3379/DUHS//Approval/2024/175

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.